Achievement of more stringent disease control is associated with reduced burden on workplace and household productivity: results from long-term certolizumab pegol treatment in patients with psoriatic arthritis.
William TillettLaura C CoatesSandeep KiriVanessa TaiebDamon WillemsPhilip J MeasePublished in: Therapeutic advances in musculoskeletal disease (2022)
study demonstrates the cumulative workplace and household work productivity benefits for patients with PsA when achieving more stringent thresholds of disease control with certolizumab pegol treatment.